Designing a National Strategy for Healthcare
In an effort to increase patient safety, members of the healthcare industry are collaborating to implement standardized bar codes on all aspects of
Headed jointly by the Institute for Safe Medication Practices Canada (ISMP Canada) and the Canadian Patient Safety Institute (CPSI), the initiative is guided
by a national Implementation Committee and being developed with assistance
from a 34-member Technical Task Force (TTF), representing six identified healthcare sectors.
- GS1 Canada Technical Support
ISMP Canada and CPSI jointly endorsed the adoption of the GS1 global standard for automated identification (e.g., bar coding) of pharmaceutical products in Canada.
The multiphase project has developed draft technical requirements for Canadian pharmaceuticals in the following areas: bar code components and symbologies, product database elements, medications to be included in the categories to be bar coded, and packaging levels and bar code placement.
- Joint Technical Statement
Current commercial pharmaceutical automated identification (bar code) technical recommendations, based on the pan-Canadian adoption of the GS1 global standard, are contained in the "Joint Technical Statement on Pharmaceutical Automated Identification and Product Database Requirements". This document was updated and re-issued as Version II; 2012 in February 2012.
- Resource Guide
Healthcare practice guidance related to the acquisition and incorporation of medication bar code systems into patient care operations are found in the Medication Bar Code System Implementation Planning: A Resource Guide, issued October 2013.
Collaborating Health Sectors:
- Pharmaceutical Manufacturers
- Retail Pharmacies
- Institutional Pharmacies
- Professional Practice Organizations
- Healthcare Solution Providers
- Supply Chain and Public Purchasing Organizations
CURRENT PROJECT ACTIVITIES
Phase III: Dissemination and Stakeholder Engagement
- To identify and contact stakeholders in all Canadian health sectors.
- To assure they are aware of the Joint Technical Statement, and to seek their support.
- To affect knowledge transfer to all healthcare workers in each sector, and the public.
- To continue the collaborative environment to promote medication safety through automated practice integration using bar coding.
- To develop a sustainability strategy to assure the long-term adoption of the Joint Technical Statement components.
Phase IV: Implementation Progress
- Promote Pharmaceutical Manufacturer and Health Technology Provider uptake
- Promote professional practice and safety and practice organizations' support
- Collaborate with public Group Purchasing Organizations' for contracting support
- Provide guidelines for the placement of bar codes on pharmaceutical labels
- To develop end-user bar code implementation resources
FINANCIAL SUPPORT HAS BEEN PROVIDED BY:
- Medbuy Corporation
- HealthPRO Procurement Services Inc
- Healthcare Insurance Reciprocal of Canada (HIROC)
- Baxter Corporation
- Pharmaceutical Partners of Canada Inc (PPC)
- AstraZeneca Canada Inc
- Eli Lilly Canada Inc
- McKesson Canada
- Pfizer Canada Inc
- Sandoz Canada Inc
- Sanofi Canada Inc
- TEVA Novopharm Ltd
The following organizations are members of the Implementation Advisory Committee for the project:
- Canada Health Infoway
- Canada's Research-Based Pharmaceutical Companies
- Canadian Association for Pharmacy Distribution Management
- Canadian Association of Chain Drug Stores
- Canadian Generic Pharmaceutical Association
- Canadian Patient Safety Institute
- Canadian Society of Hospital Pharmacists
- Group Purchasing Organization Alliance (currently includes Approvisionnement-Montréal, HealthPRO, and Medbuy Corporation)
- GS1 Canada
- Institute for Safe Medication Practices Canada
- Public Health Agency of Canada